- Home
- CEPU vs ZLAB Comparison
CEPU vs ZLAB Comparison
Compare CEPU & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CEPU | ZLAB |
|---|---|---|
| Founded | 1989 | 2013 |
| Country | Argentina | China |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CEPU | ZLAB |
|---|---|---|
| Price | $15.07 | $17.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $17.50 | ★ $49.60 |
| AVG Volume (30 Days) | 321.8K | ★ 795.4K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $460,156,000.00 |
| Revenue This Year | $10.11 | $9.75 |
| Revenue Next Year | N/A | $26.03 |
| P/E Ratio | $12.24 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $7.43 | $15.96 |
| 52 Week High | $18.50 | $44.34 |
Technical Indicators
Market Signals| Indicator | CEPU | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 52.42 | 33.89 |
| Support Level | $14.84 | $17.11 |
| Resistance Level | $15.56 | $19.64 |
| Average True Range (ATR) | 0.70 | 0.68 |
| MACD | 0.19 | -0.20 |
| Stochastic Oscillator | 55.77 | 16.20 |
Price Performance
Historical ComparisonAbout CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.